Hong Du

2.6k total citations
79 papers, 1.8k citations indexed

About

Hong Du is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hong Du has authored 79 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 20 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Hong Du's work include Gastric Cancer Management and Outcomes (12 papers), Cancer-related molecular mechanisms research (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Hong Du is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Cancer-related molecular mechanisms research (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Hong Du collaborates with scholars based in China, Ethiopia and United States. Hong Du's co-authors include Jiafu Ji, Xiaojing Cheng, Xiaofang Xing, Ying Hu, Xiaodong Li, Weipu Zhu, Lianhai Zhang, Ting Guo, Xianzi Wen and Lilong Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Hong Du

76 papers receiving 1.8k citations

Peers

Hong Du
Weiqi Lu China
Dake Chu China
Lihua Qiu China
Qida Hu China
Jin Tao China
Hong Zong China
Olga Martinho Portugal
Weiqi Lu China
Hong Du
Citations per year, relative to Hong Du Hong Du (= 1×) peers Weiqi Lu

Countries citing papers authored by Hong Du

Since Specialization
Citations

This map shows the geographic impact of Hong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Du more than expected).

Fields of papers citing papers by Hong Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Du. The network helps show where Hong Du may publish in the future.

Co-authorship network of co-authors of Hong Du

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Du. A scholar is included among the top collaborators of Hong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Du. Hong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, G., et al.. (2025). Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors. ImmunoTargets and Therapy. Volume 14. 655–680. 3 indexed citations
2.
Kang, Zhijun, et al.. (2025). PC3D-YOLO: An Enhanced Multi-Scale Network for Crack Detection in Precast Concrete Components. Buildings. 15(13). 2225–2225.
3.
Zhou, Linkang, You Lu, Xiaoxue Qiu, et al.. (2025). Lipid droplet efferocytosis attenuates proinflammatory signaling in macrophages via TREM2- and MS4A7-dependent mechanisms. Cell Reports. 44(2). 115310–115310. 4 indexed citations
4.
Wang, Yuqin, Hui Hui, Jing Han, et al.. (2025). A CLDN18.2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer. Advanced Science. 12(16). e2413913–e2413913. 2 indexed citations
5.
Huangfu, Longtao, Yongqi Wang, Biao Fan, et al.. (2024). The deubiquitinase USP15 drives malignant progression of gastric cancer through glucose metabolism remodeling. Journal of Experimental & Clinical Cancer Research. 43(1). 235–235. 5 indexed citations
6.
Ma, Xiaoxiao, Shuqin Jia, Min Liang, et al.. (2023). TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal Transduction and Targeted Therapy. 8(1). 246–246. 51 indexed citations
7.
Li, Lin, et al.. (2023). Death receptor 5 promotes tumor progression in gastric cancer. FEBS Open Bio. 13(12). 2375–2388. 2 indexed citations
8.
Deng, Ziqian, Ting Guo, Ying Hu, et al.. (2023). Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction. Journal of Translational Medicine. 21(1). 638–638. 4 indexed citations
9.
Shen, Li, Yiding Wang, Hong Du, et al.. (2023). Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer. International Journal of Molecular Sciences. 24(6). 5482–5482. 5 indexed citations
10.
Han, Jing, Cong Chen, Xiaojing Cheng, et al.. (2022). SDCBP‐AS1 destabilizes β‐catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis. Cancer Communications. 42(11). 1141–1161. 13 indexed citations
11.
Xing, Xiaofang, Jinyao Shi, Yongning Jia, et al.. (2022). Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis. Journal for ImmunoTherapy of Cancer. 10(3). e003984–e003984. 40 indexed citations
12.
Guo, Ting, Yanhua Bai, Xiaojing Cheng, et al.. (2021). Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4. Cancer Communications. 41(3). 258–272. 28 indexed citations
13.
Han, Jing, Cong Chen, Xiaojing Cheng, et al.. (2021). CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways. International Journal of Biological Sciences. 17(11). 2841–2852. 18 indexed citations
14.
Zhang, Ershuai, Boyi Song, Yuanjie Shi, et al.. (2020). Fouling-resistant zwitterionic polymers for complete prevention of postoperative adhesion. Proceedings of the National Academy of Sciences. 117(50). 32046–32055. 81 indexed citations
15.
McGonigle, Sharon, Utpal Majumder, Donna Kolber‐Simonds, et al.. (2019). Neuropilin-1 drives tumor-specific uptake of chlorotoxin. Cell Communication and Signaling. 17(1). 67–67. 18 indexed citations
16.
Xing, Xiaofang, Bin Dong, Xiaojing Cheng, et al.. (2018). Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer. Cancer Management and Research. Volume 10. 4969–4980. 19 indexed citations
17.
Yuan, Peng, Xiaojing Cheng, Xiaojiang Wu, et al.. (2016). OSMR and SEPT9: promising biomarkers for detection of colorectal cancer based on blood-based tests. Translational Cancer Research. 5(2). 131–139. 5 indexed citations
18.
Xing, Xiaofang, Shenyi Lian, Ying Hu, et al.. (2013). Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. Journal of Translational Medicine. 11(1). 309–309. 25 indexed citations
19.
Xing, Xiaofang, Lianhai Zhang, Xiaohong Wang, Hong Du, & Jiafu Ji. (2012). 16. Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026